Sign in
4

Changes in Ownership

Edesa Biotech, Inc. Filed Acc 0001171843-25-000868

Options or other derivatives

  • Chief Executive Officer acquired 100 shares (grant or award)

From the SEC's structured data for this filing

Trades in this filing

Nijhawan Pardeep · Chief Executive Officer

Table II: Derivative

1 line
Date Transaction Shares Owned after D/I
2025-02-12 Grant or award : show line 1 in the form Series B-1 Convertible Preferred Shares +100 100 D
Loading xslF345X05/ownership.xml…